Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Standard BioTools Inc. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
CC
Casdin Capital, LLC
13D · 22.7%
|
88.8M | 22.62% | Unchanged | 2023 | 3.7% | |
|
Shares held by quarter
Peak holding88.8M (Q4'25)
Change over 8 quarters+17.5M
Share of the company22.620%
Disclosed stake13D · 22.7%
|
||||||
|
VG
Viking Global Investors LP
13D · 15.0%
|
58.7M | 14.94% | Unchanged | 2024 | 0.1% | |
|
Shares held by quarter
Peak holding58.7M (Q3'24)
Change over 8 quarters0
Share of the company14.940%
Disclosed stake13D · 15.0%
|
||||||
28 more super investors behind a free account
See every manager holding Standard BioTools Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$6.94M | 8.4M | 2.15% | 0.00% | June 30, 2026 |
|
IR
iShares Trust
|
$6.56M | 7.1M | 1.82% | 0.01% | March 31, 2026 |
23 more funds behind a free account
See every fund holding Standard BioTools Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
EC
Eli Casdin
5%+ holder
13D · 23.9%
|
93.8M | 23.90% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
CP
Casdin Partners Master Fund, L.P.
5%+ holder
13D · 18.5%
|
72.1M | 18.37% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
11 more holders behind a free account
See every insider and 5%+ holder of Standard BioTools Inc..
Sign up freeLoading...